Published on
Diagnostic Tests – Pro-Insulin

1. What is this test for?

The pro-insulin assay is used to help determine the cause of hypoglycemia, specifically to differentiate endogenous insulin overproduction from other etiologies. It is particularly useful for distinguishing insulinoma from autoimmune or exogenous causes of hypoglycemia.

2. What do high levels of pro-insulin represent?

Elevated pro-insulin levels strongly suggest the presence of an insulinoma. Insulinomas secrete excessive amounts of insulin and incompletely processed insulin precursors, leading to disproportionately high pro-insulin concentrations compared with normal physiology.

3. When do you answer pro-insulin levels?


You should choose a pro-insulin level in cases of recurrent fasting hypoglycemia, especially when the patient presents with symptoms such as weakness, confusion, diaphoresis, or tremors and laboratory findings show inappropriately elevated C-peptide levels. This combination indicates endogenous insulin secretion and points toward insulinoma as the underlying diagnosis rather than surreptitious insulin use or autoimmune hypoglycemia.





Picture
Published on
Diagnostic Tests: 24-Hour Urine Cortisol Level

Diagnoses for Which This Is the Most Sensitive Test


The 24-hour urinary free cortisol level is the most sensitive screening test for endogenous hypercortisolism and is the best initial test for diagnosing Cushing’s syndrome. Because cortisol secretion is variable and follows a diurnal rhythm, a 24-hour urine collection provides an integrated measurement of cortisol production over an entire day, making it more reliable than a single serum cortisol level.


What This Substance Is

Cortisol is a glucocorticoid hormone produced by the adrenal cortex. It plays a key role in metabolism, immune regulation, blood pressure control, and the physiologic response to stress. Excess cortisol leads to the characteristic physical and metabolic abnormalities seen in Cushing’s syndrome.


When to Answer Urinary Free Cortisol

You should choose 24-hour urinary free cortisol when the clinical presentation suggests Cushing’s syndrome. Classic features include:


  • Truncal (central) obesity
  • “Buffalo hump”
  • Purple striae
  • Easy bruising
  • Proximal muscle weakness
  • Hypertension or glucose intolerance

In exam questions, the correct best initial test for suspected Cushing’s syndrome is either 24-hour urine cortisol or the overnight dexamethasone suppression test.



Picture
Published on
Diagnostic Tests: Oral Glucose Tolerance Testing (OGTT)

Overview — What This Test Is


The oral glucose tolerance test (OGTT) measures the body’s ability to handle a glucose load. Serum glucose levels are obtained at baseline (fasting) and again 2 hours after ingestion of 75 grams of oral glucose. The test assesses pancreatic insulin secretion and peripheral insulin sensitivity and is useful for detecting abnormalities in glucose metabolism that may not be apparent on fasting glucose measurements alone.


What Constitutes a Positive Test

An OGTT is considered positive for diabetes mellitus when:


  • 2-hour plasma glucose ≥ 200 mg/dL




This is one accepted diagnostic criterion for diabetes.
For comparison, diabetes can also be diagnosed by:


  • Two fasting plasma glucose values ≥ 126 mg/dL




OGTT is particularly sensitive because it challenges the pancreas with a glucose load, revealing early or subtle defects in glucose handling.


When OGTT Is the Most Accurate Diagnostic Test

The most important and high-yield indication for OGTT is screening for diabetes during pregnancy, specifically gestational diabetes mellitus (GDM). Pregnancy represents a limited time window in which:


  • Glucose intolerance can worsen rapidly
  • Undiagnosed diabetes can cause significant fetal harm
  • Early detection allows timely intervention


OGTT is especially valuable because it can uncover glucose intolerance not detected by routine fasting glucose testing, effectively “stress-testing” pancreatic function.




Picture
Published on
Diagnostic Tests: TSH, Thyroxine (T4), and Thyroglobulin


Clinical Scenarios for Which These Tests Are Used


TSH and thyroxine (T4) are used to evaluate thyroid function, including both hypothyroidism and hyperthyroidism. They are the cornerstone tests for assessing whether the thyroid gland is underactive or overactive and for determining whether dysfunction is primary (thyroid-related) or secondary (pituitary-related).


Thyroglobulin, in contrast, is not a test of thyroid function. It is used specifically to monitor disease recurrence or treatment response in patients who have been treated for papillary or follicular thyroid cancer.


⸻


What These Substances Are


Thyroid-stimulating hormone (TSH) is produced by the anterior pituitary gland and regulates thyroid hormone production by stimulating the thyroid gland.


Thyroxine (T4) is one of the principal hormones produced by the thyroid gland and plays a key role in regulating metabolism, growth, and development. It is synthesized in the thyroid and later converted to the more active triiodothyronine (T3) in peripheral tissues.


Thyroglobulin is an iodine-containing glycoprotein synthesized by thyroid follicular cells. It serves as the storage form and precursor for thyroid hormone production within the thyroid gland. It should not be confused with thyroid-binding globulin, which is a plasma transport protein.


⸻


When to Answer TSH and Thyroxine (T4)


TSH and T4 are always the best initial tests when evaluating any suspected thyroid disorder. You should choose these tests when a patient presents with symptoms suggestive of:
• Hypothyroidism (fatigue, weight gain, cold intolerance, constipation)
• Hyperthyroidism (weight loss, heat intolerance, tremor, palpitations)
• Goiter or thyroid nodules
• Abnormal vital signs or unexplained metabolic changes


Together, TSH and T4 provide the most reliable initial assessment of thyroid status.


⸻


When to Answer Thyroglobulin


Thyroglobulin should be selected when the clinical question involves follow-up or surveillance of differentiated thyroid cancer, specifically:
• Papillary thyroid carcinoma
• Follicular thyroid carcinoma


After thyroidectomy and radioactive iodine ablation, thyroglobulin levels should be undetectable or very low. A rising thyroglobulin level suggests recurrent or residual thyroid cancer. It is not used to diagnose thyroid cancer initially and not used to assess thyroid function.
Picture
Published on
Diagnostic Tests: IGF-1 (Insulin-Like Growth Factor-1)


Diseases for Which IGF-1 Is the Best Initial Test


Serum IGF-1 measurement is the single best initial screening test for acromegaly. Because growth hormone (GH) secretion is pulsatile and varies throughout the day, a random GH level is unreliable. IGF-1 levels, however, are stable and reflect average GH secretion over time, making them ideal for diagnosing GH excess.


What IGF-1 Is

IGF-1 is a somatomedin produced primarily by the liver in response to growth hormone stimulation. In children, IGF-1 mediates linear skeletal growth when GH acts in conjunction with thyroid hormone. In both children and adults, IGF-1 promotes protein synthesis in muscle (anabolic effects) and lipolysis in adipose tissue (catabolic effects). Because IGF-1 has a longer half-life and minimal diurnal variation, it provides a reliable measure of GH activity.


Best Test to Confirm the Diagnosis


The best confirmatory test for acromegaly is the oral glucose tolerance test (OGTT). Under normal conditions, glucose ingestion suppresses GH secretion. In acromegaly, GH levels fail to suppress after glucose administration, confirming autonomous GH production.


Most Common Wrong Answer

The most common incorrect answer for confirming acromegaly is measuring random growth hormone (GH) levels. Because GH is secreted in pulses, a single measurement may be normal despite active disease and should not be used as a confirmatory test.





Picture
Published on


Diagnostic Tests: Beta–Human Chorionic Gonadotropin (β-hCG)

Overview — What This Test Is

Beta–human chorionic gonadotropin (β-hCG) is a hormone produced by the placenta shortly after implantation. Measurement of β-hCG in urine or serum is used to detect pregnancy. Serum testing is more sensitive than urine testing and allows for quantitative measurement, which is useful for monitoring early pregnancy progression and identifying abnormal pregnancies.


When β-hCG Is the Correct Answer

β-hCG is the best initial diagnostic test for any woman of reproductive age who presents with symptoms that could indicate pregnancy or pregnancy-related complications. You should answer β-hCG when the clinical scenario includes:
  • Amenorrhea or a missed/delayed period
  • Vaginal bleeding
  • Lower abdominal or pelvic pain
  • Unexplained abdominal pain in a woman of childbearing age

A key exam principle is that any unexplained abdominal pain in a woman of reproductive age should be considered an ectopic pregnancy until proven otherwise, and β-hCG must be obtained first before further imaging or intervention.



Picture
Published on
Diagnostic Tests: C-Peptide

Overview — What This Test Is

The C-peptide test measures the serum level of C-peptide, a byproduct released when proinsulin is cleaved into insulin within pancreatic β-cells. Because C-peptide is secreted only with endogenous insulin and is absent in injected (exogenous) insulin, it is the best test for distinguishing endogenous from exogenous hyperinsulinemia in patients presenting with hypoglycemia.


Interpretation of Low C-Peptide Levels

Low C-peptide levels in the setting of hypoglycemia indicate exogenous insulin administration. In this situation, insulin levels are elevated, but C-peptide is suppressed because the insulin is being injected rather than produced by the pancreas. This finding is classic for factitious hypoglycemia, often due to insulin abuse, and may be seen in patients with psychiatric disease or repeated unexplained hospital visits.

Interpretation of High C-Peptide Levels

High C-peptide levels reflect endogenous insulin production. This occurs when the pancreas is actively secreting insulin, such as in:


  • Insulinoma
  • Sulfonylurea use, which stimulates pancreatic insulin release

In these cases, both insulin and C-peptide levels are elevated during episodes of hypoglycemia.

When to Choose a C-Peptide Level

You should answer C-peptide level when a patient presents with:


  • Unexplained hypoglycemia
  • Elevated insulin levels
  • Recurrent or unexplained hospital admissions
  • Suspicion of factitious disorder or insulin-secreting tumor


In exam questions, C-peptide is the next best diagnostic step to determine the cause of hyperinsulinemic hypoglycemia and to differentiate insulin abuse from endogenous insulin excess.


Picture
Published on
Diagnostic Tests: Prenatal Screening

Routine Prenatal Screening Tests


Basic prenatal screening is recommended for all pregnancies to assess maternal health, identify infectious risks, and evaluate fetal development. These tests are part of standard obstetric care and are not dependent on maternal age or risk status. Routine prenatal screening includes cervical cytology, a complete blood count (CBC), and urinalysis to detect anemia, infection, or renal abnormalities. Maternal blood testing also includes blood group, Rh factor, and antibody screening to prevent hemolytic disease of the newborn, along with serologic testing for syphilis and assessment of rubella immunity.


Additional routine evaluations include glucose screening for gestational diabetes and fetal ultrasound for pregnancy dating, growth monitoring, and anatomic assessment. Cervical cultures are obtained to screen for Neisseria gonorrhoeae, Chlamydia trachomatis, and Group B Streptococcus, which are important causes of maternal and neonatal infection.


High-Risk Pregnancies and Mothers Over Age 35

In high-risk pregnancies, particularly in women 35 years of age or older, additional testing is required because of the increased risk of chromosomal abnormalities. In these cases, the appropriate diagnostic approach is chromosomal screening for fetal abnormalities.


On exams, when the clinical stem emphasizes advanced maternal age or otherwise labels the pregnancy as high risk, the correct answer is chromosomal screening, rather than repeating routine prenatal laboratory tests.






.


Picture
Published on
Diagnostic Tests: Pelvic Laparoscopy


Overview — What This Test Is

Pelvic laparoscopy is a minimally invasive surgical procedure that allows direct visualization of pelvic structures through small abdominal incisions using a laparoscope. Because it provides real-time, direct inspection, pelvic laparoscopy is considered the most accurate diagnostic test for several gynecologic conditions, particularly when noninvasive imaging is inconclusive.


It can also be diagnostic and therapeutic, allowing for immediate intervention during the same procedure.


Conditions Best Diagnosed With Pelvic Laparoscopy

Pelvic laparoscopy is the most accurate test for diagnosing:


  • Ectopic pregnancy
  • Pelvic inflammatory disease (PID), especially complicated or refractory cases
  • Endometriosis
  • Ovarian or pelvic cysts
  • Chronic pelvic pain of unclear etiology


When Pelvic Laparoscopy Is the Correct Answer

Choose pelvic laparoscopy in high-risk or unclear cases where rapid, definitive diagnosis is required:


  • Pelvic pain with vaginal bleeding and a positive β-hCG, particularly when:
    • The β-hCG level is lower than expected for the estimated gestational age
    • There is concern for ectopic pregnancy

  • Persistent lower abdominal pain in a woman treated for PID who shows an incomplete response to antibiotics, and pregnancy has been excluded


In these scenarios, laparoscopy allows immediate confirmation and management of potentially life-threatening or refractory pelvic conditions.


Picture
Published on
Diagnostic Tests: Diagnostic Peritoneal Lavage (DPL)

When to Answer DPL

Diagnostic peritoneal lavage is indicated in the setting of blunt abdominal trauma when the patient is hemodynamically unstable or unconscious and the abdomen cannot be reliably examined. The classic scenario is a comatose or intoxicated trauma patient with multiple injuries and unexplained shock, where rapid determination of intra-abdominal bleeding is required. In this procedure, a catheter is placed into the peritoneal cavity, saline is infused, then aspirated and analyzed for evidence of injury.




Patients in Whom DPL Should NOT Be Used

DPL is not appropriate in several important clinical situations:


  • Patients with signs of an acute abdomen
    Any evidence of a perforated viscus or clear intra-abdominal bleeding mandates immediate surgical exploration, not DPL.
  • Patients with gunshot wounds to the abdomen
    Penetrating abdominal trauma from firearms is an indication for direct surgical exploration.
  • Hemodynamically stable patients with abdominal trauma
    If the patient is stable and there are no definitive signs of perforation on physical exam, the correct study is an abdominal CT scan, not DPL.


Findings That Make DPL Positive

A DPL is considered positive when any of the following are found in the aspirated fluid:


  • Red blood cells >100,000/mm³
  • White blood cells >500/mm³
  • Presence of bile
  • Presence of feces


Any of these findings indicates significant intra-abdominal injury requiring surgical intervention.


What DPL Misses

A major limitation of DPL is that it is inadequate for detecting retroperitoneal injuries. Injuries to retroperitoneal structures such as the pancreas, kidneys, duodenum, or great vessels may be missed, making CT imaging superior in stable patients.






Picture